Around one in five people may be suffering with obstructive sleep apnea (OSA), according to a study published in ERJ Open Research.
May 10, 2023
0
14
McMaster University researchers Dena Zeraatkar and Tyler Pitre have found that the drug solriamfetol is the most effective treatment for excessive daytime sleepiness (EDS) for people with obstructive sleep apnea (OSA).
May 8, 2023
0
3
The U.S. Food & Drug Administration has approved Lumryz for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. Lumryz is an extended-release formulation of sodium oxybate to be taken once ...
May 5, 2023
0
3
Obesity induced by a high-fat diet (HFD) is a growing epidemic and major health concern. While excessive daytime sleepiness (EDS) is a pervasive symptom of HFD-induced obesity, research findings suggest that reduced wakefulness ...
Nov 4, 2022
0
4
Researchers at Columbia University Mailman School of Public Health evaluated an expanded measure of cardiovascular health (CVH) that includes sleep as an eighth metric, in relation to cardiovascular disease risk. This represents ...
Oct 19, 2022
0
26
People with the inherited disorder myotonic dystrophy (DM) often experience excessive daytime sleepiness and fatigue, as well as altered responses to anesthetics that can put them at risk for complications when hospitalized.
Sep 29, 2022
0
16
Every night when we go to sleep, we spend a couple of hours in a virtual world created by our brains in which we are the main protagonist of an unfolding story we did not consciously create. In other words, we dream.
Jun 24, 2022
0
274
Obstructive sleep apnoea (OSA) is a common breathing disorder causing excessive daytime sleepiness and increasing the risk for cardiovascular disease, hypertension, and stroke. OSA is characterized by repetitive complete ...
Jan 4, 2022
0
0
More than two thirds (65.5 percent) of students are experiencing poor sleep quality and this is linked to mental health problems, new research published in the peer-reviewed journal Annals of Human Biology suggests.
Nov 2, 2021
0
17
(HealthDay)—The drug Xywav has been approved for expanded use in adults with a rare sleep disorder called idiopathic hypersomnia, the U.S. Food and Drug Administration said Thursday.
Aug 13, 2021
0
2
